Apollomics Inc. (APLM) stock
APLMNasdaqPharmaceutical PreparationsFiscal year ends December 31Also trades as APLMW
$17.84+0.16 (+0.90%)
Close on Nov 16, 2026Market cap $39.18MP/E –Yield –
Apollomics price to sales ratio
The price-to-sales ratio is market cap divided by revenue over the trailing twelve months.
Apollomics's price to sales ratio was 3.2× on Nov 11, 2026.
Price to Sales Ratio at the end of each year
| Period | Period end | Value | Change (pts) |
|---|---|---|---|
| 2026 | Nov 11, 2026 | 3.2× | – |
See a number that looks wrong?